{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:26:05Z","timestamp":1778261165355,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903569"],"award-info":[{"award-number":["81903569"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02981-5","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T18:19:37Z","timestamp":1763576377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma metabolomics disentangles T2DM- and CAD-specific dysmetabolism and identifies potential biomarkers for CAD risk escalation in diabetic patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Ting","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoling","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"2981_CR1","unstructured":"Magliano DJ, Boyko EJ, I.D.F.D.A.t.e.s. committee, IDF Diabetes Atlas, Idf diabetes atlas, International Diabetes Federation \u00a9 International Diabetes Federation, 2021., Brussels, 2021."},{"key":"2981_CR2","doi-asserted-by":"publisher","DOI":"10.1172\/jci142243","author":"SI Taylor","year":"2021","unstructured":"Taylor SI, Yazdi ZS, Beitelshees AL. Pharmacological treatment of hyperglycemia in type 2 diabetes. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci142243.","journal-title":"J Clin Invest"},{"issue":"5","key":"2981_CR3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","volume":"28","author":"ATN Nair","year":"2022","unstructured":"Nair ATN, Wesolowska-Andersen A, Brorsson C, Rajendrakumar AL, Hapca S, Gan S, et al. Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nat Med. 2022;28(5):982\u20138. https:\/\/doi.org\/10.1038\/s41591-022-01790-7.","journal-title":"Nat Med"},{"issue":"9","key":"2981_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nrendo.2009.150","volume":"5","author":"SW Zarich","year":"2009","unstructured":"Zarich SW. Antidiabetic agents and cardiovascular risk in type 2 diabetes. Nat Rev Endocrinol. 2009;5(9):500\u20136. https:\/\/doi.org\/10.1038\/nrendo.2009.150.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2981_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024;9(1):262. https:\/\/doi.org\/10.1038\/s41392-024-01951-9.","journal-title":"Signal Transduct Target Ther"},{"key":"2981_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-015-0260-x","volume":"14","author":"SK Paul","year":"2015","unstructured":"Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:100. https:\/\/doi.org\/10.1186\/s12933-015-0260-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"2981_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685\u201395. https:\/\/doi.org\/10.1038\/s41569-023-00877-z.","journal-title":"Nat Rev Cardiol"},{"issue":"10085","key":"2981_CR8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/s0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239\u201351. https:\/\/doi.org\/10.1016\/s0140-6736(17)30058-2.","journal-title":"Lancet"},{"issue":"8","key":"2981_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.amjmed.2021.03.011","volume":"134","author":"DL Li","year":"2021","unstructured":"Li DL, Kronenberg MW. Myocardial perfusion and viability imaging in coronary artery disease: clinical value in diagnosis, prognosis, and therapeutic guidance. Am J Med. 2021;134(8):968\u201375. https:\/\/doi.org\/10.1016\/j.amjmed.2021.03.011.","journal-title":"Am J Med"},{"issue":"20","key":"2981_CR10","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/circulationaha.119.040631","volume":"140","author":"AP DeFilippis","year":"2019","unstructured":"DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation. 2019;140(20):1661\u201378. https:\/\/doi.org\/10.1161\/circulationaha.119.040631.","journal-title":"Circulation"},{"key":"2981_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpba.2014.12.017","volume":"113","author":"R Bujak","year":"2015","unstructured":"Bujak R, Struck-Lewicka W, Markuszewski MJ, Kaliszan R. Metabolomics for laboratory diagnostics. J Pharm Biomed Anal. 2015;113:108\u201320. https:\/\/doi.org\/10.1016\/j.jpba.2014.12.017.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"2981_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","volume":"8","author":"S Qiu","year":"2023","unstructured":"Qiu S, Cai Y, Yao H, Lin C, Xie Y, Tang S, et al. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):132. https:\/\/doi.org\/10.1038\/s41392-023-01399-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2981_CR13","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1038\/s41467-024-50125-2","volume":"15","author":"J Lv","year":"2024","unstructured":"Lv J, Pan C, Cai Y, Han X, Wang C, Ma J, et al. Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease. Nat Commun. 2024;15(1):5729. https:\/\/doi.org\/10.1038\/s41467-024-50125-2.","journal-title":"Nat Commun"},{"issue":"2","key":"2981_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/circresaha.120.315890","volume":"128","author":"M Nayor","year":"2021","unstructured":"Nayor M, Brown KJ, Vasan RS. The molecular basis of predicting atherosclerotic cardiovascular disease risk. Circ Res. 2021;128(2):287\u2013303. https:\/\/doi.org\/10.1161\/circresaha.120.315890.","journal-title":"Circ Res"},{"issue":"1","key":"2981_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12933-022-01494-9","volume":"21","author":"E Karagiannidis","year":"2022","unstructured":"Karagiannidis E, Moysidis DV, Papazoglou AS, Panteris E, Deda O, Stalikas N, et al. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease. Cardiovasc Diabetol. 2022;21(1):70. https:\/\/doi.org\/10.1186\/s12933-022-01494-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2981_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41591-022-01686-6","volume":"28","author":"Y Talmor-Barkan","year":"2022","unstructured":"Talmor-Barkan Y, Bar N, Shaul AA, Shahaf N, Godneva A, Bussi Y, et al. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nat Med. 2022;28(2):295\u2013302. https:\/\/doi.org\/10.1038\/s41591-022-01686-6.","journal-title":"Nat Med"},{"issue":"11","key":"2981_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/circresaha.120.315898","volume":"126","author":"Z-Z Chen","year":"2020","unstructured":"Chen Z-Z, Gerszten RE. Metabolomics and proteomics in type 2 diabetes. Circ Res. 2020;126(11):1613\u201327. https:\/\/doi.org\/10.1161\/circresaha.120.315898.","journal-title":"Circ Res"},{"key":"2981_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.lfs.2018.09.035","volume":"212","author":"N Wang","year":"2018","unstructured":"Wang N, Zhu F, Chen L, Chen K. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications. Life Sci. 2018;212:194\u2013202. https:\/\/doi.org\/10.1016\/j.lfs.2018.09.035.","journal-title":"Life Sci"},{"issue":"10","key":"2981_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","volume":"19","author":"Q Yang","year":"2018","unstructured":"Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654\u201372. https:\/\/doi.org\/10.1038\/s41580-018-0044-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2981_CR20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/circresaha.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah RW, Crown SB, Zhang GF, Shah SH, Newgard CB. Cardiovascular metabolomics. Circ Res. 2018;122(9):1238\u201358. https:\/\/doi.org\/10.1161\/circresaha.117.311002.","journal-title":"Circ Res"},{"issue":"21","key":"2981_CR21","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1021\/acs.analchem.1c05502","volume":"94","author":"X Ding","year":"2022","unstructured":"Ding X, Yang F, Chen Y, Xu J, He J, Zhang R, et al. Norm ISWSVR: a data integration and normalization approach for large-scale metabolomics. Anal Chem. 2022;94(21):7500\u20139. https:\/\/doi.org\/10.1021\/acs.analchem.1c05502.","journal-title":"Anal Chem"},{"key":"2981_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10010008","author":"NA Reisdorph","year":"2019","unstructured":"Reisdorph NA, Walmsley S, Reisdorph R. A perspective and framework for developing sample type specific databases for LC\/MS-based clinical metabolomics. Metabolites. 2019. https:\/\/doi.org\/10.3390\/metabo10010008.","journal-title":"Metabolites"},{"issue":"8","key":"2981_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nbt0807-846b","volume":"25","author":"SA Sansone","year":"2007","unstructured":"Sansone SA, Fan T, Goodacre R, Griffin JL, Hardy NW, Kaddurah-Daouk R, et al. The metabolomics standards initiative. Nat Biotechnol. 2007;25(8):846\u20138. https:\/\/doi.org\/10.1038\/nbt0807-846b.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2981_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2018.18269","volume":"321","author":"J Rosenstock","year":"2019","unstructured":"Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, et al. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial. JAMA. 2019;321(1):69\u201379. https:\/\/doi.org\/10.1001\/jama.2018.18269.","journal-title":"JAMA"},{"issue":"15","key":"2981_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1608664.","journal-title":"N Engl J Med"},{"issue":"5","key":"2981_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1161\/circresaha.122.321253","volume":"131","author":"H Xue","year":"2022","unstructured":"Xue H, Chen X, Yu C, Deng Y, Zhang Y, Chen S, et al. Gut microbially produced indole-3-propionic acid inhibits atherosclerosis by promoting reverse cholesterol transport and its deficiency is causally related to atherosclerotic cardiovascular disease. Circ Res. 2022;131(5):404\u201320. https:\/\/doi.org\/10.1161\/circresaha.122.321253.","journal-title":"Circ Res"},{"issue":"1","key":"2981_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","volume":"7","author":"H Liu","year":"2019","unstructured":"Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, et al. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome. 2019;7(1):68. https:\/\/doi.org\/10.1186\/s40168-019-0683-9.","journal-title":"Microbiome"},{"key":"2981_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2023.101235","volume":"91","author":"V Petrenko","year":"2023","unstructured":"Petrenko V, Sinturel F, Riezman H, Dibner C. Lipid metabolism around the body clocks. Prog Lipid Res. 2023;91:101235. https:\/\/doi.org\/10.1016\/j.plipres.2023.101235.","journal-title":"Prog Lipid Res"},{"issue":"4","key":"2981_CR29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2337\/dc21-1705","volume":"45","author":"J Morze","year":"2022","unstructured":"Morze J, Wittenbecher C, Schwingshackl L, Danielewicz A, Rynkiewicz A, Hu FB, et al. Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies. Diabetes Care. 2022;45(4):1013\u201324. https:\/\/doi.org\/10.2337\/dc21-1705.","journal-title":"Diabetes Care"},{"issue":"5","key":"2981_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/10408363.2019.1711360","volume":"57","author":"S Softic","year":"2020","unstructured":"Softic S, Stanhope KL, Boucher J, Divanovic S, Lanaspa MA, Johnson RJ, et al. Fructose and hepatic insulin resistance. Crit Rev Clin Lab Sci. 2020;57(5):308\u201322. https:\/\/doi.org\/10.1080\/10408363.2019.1711360.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"2981_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jhep.2021.02.027","volume":"75","author":"B Geidl-Flueck","year":"2021","unstructured":"Geidl-Flueck B, Hochuli M, N\u00e9meth \u00c1, Eberl A, Derron N, K\u00f6feler HC, et al. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: a randomized controlled trial. J Hepatol. 2021;75(1):46\u201354. https:\/\/doi.org\/10.1016\/j.jhep.2021.02.027.","journal-title":"J Hepatol"},{"issue":"1","key":"2981_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13054-023-04552-0","volume":"27","author":"Y Chang","year":"2023","unstructured":"Chang Y, Yoo HJ, Kim SJ, Lee K, Lim CM, Hong SB, et al. A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes. Crit Care. 2023;27(1):263. https:\/\/doi.org\/10.1186\/s13054-023-04552-0.","journal-title":"Crit Care"},{"issue":"3","key":"2981_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.7555\/jbr.38.20240053","volume":"39","author":"D Basu","year":"2024","unstructured":"Basu D. Palmitoylethanolamide, an endogenous fatty acid amide, and its pleiotropic health benefits: A narrative review. J Biomed Res. 2024;39(3):215\u201328. https:\/\/doi.org\/10.7555\/jbr.38.20240053.","journal-title":"J Biomed Res"},{"issue":"1","key":"2981_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/jxb\/erac422","volume":"74","author":"L Mohnike","year":"2023","unstructured":"Mohnike L, Huang W, Worbs B, Feussner K, Zhang Y, Feussner I. N-hydroxy pipecolic acid methyl ester is involved in Arabidopsis immunity. J Exp Bot. 2023;74(1):458\u201371. https:\/\/doi.org\/10.1093\/jxb\/erac422.","journal-title":"J Exp Bot"},{"key":"2981_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115895","volume":"169","author":"L Luo","year":"2023","unstructured":"Luo L, Cai Y, Jiang Y, Gong Y, Cai C, Lai D, et al. Pipecolic acid mitigates ferroptosis in diabetic retinopathy by regulating GPX4-YAP signaling. Biomed Pharmacother. 2023;169:115895. https:\/\/doi.org\/10.1016\/j.biopha.2023.115895.","journal-title":"Biomed Pharmacother"},{"key":"2981_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ymben.2023.03.006","volume":"77","author":"S Pauli","year":"2023","unstructured":"Pauli S, Kohlstedt M, Lamber J, Weiland F, Becker J, Wittmann C. Systems metabolic engineering upgrades Corynebacterium glutamicum for selective high-level production of the chiral drug precursor and cell-protective extremolyte L-pipecolic acid. Metab Eng. 2023;77:100\u201317. https:\/\/doi.org\/10.1016\/j.ymben.2023.03.006.","journal-title":"Metab Eng"},{"key":"2981_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","volume":"81","author":"M Neinast","year":"2019","unstructured":"Neinast M, Murashige D, Arany Z. Branched chain amino acids. Annu Rev Physiol. 2019;81:139\u201364. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114455.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"2981_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040954","volume":"19","author":"C Nie","year":"2018","unstructured":"Nie C, He T, Zhang W, Zhang G, Ma X. Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci. 2018;19(4):954. https:\/\/doi.org\/10.3390\/ijms19040954.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2981_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","volume":"20","author":"RW McGarrah","year":"2023","unstructured":"McGarrah RW, White PJ. Branched-chain amino acids in cardiovascular disease. Nat Rev Cardiol. 2023;20(2):77\u201389. https:\/\/doi.org\/10.1038\/s41569-022-00760-3.","journal-title":"Nat Rev Cardiol"},{"key":"2981_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102696","volume":"62","author":"S Zhao","year":"2023","unstructured":"Zhao S, Zhou L, Wang Q, Cao JH, Chen Y, Wang W, et al. Elevated branched-chain amino acid promotes atherosclerosis progression by enhancing mitochondrial-to-nuclear H2O2-disulfide HMGB1 in macrophages. Redox Biol. 2023;62:102696. https:\/\/doi.org\/10.1016\/j.redox.2023.102696.","journal-title":"Redox Biol"},{"issue":"9","key":"2981_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jnutbio.2005.12.001","volume":"17","author":"WS Jobgen","year":"2006","unstructured":"Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17(9):571\u201388. https:\/\/doi.org\/10.1016\/j.jnutbio.2005.12.001.","journal-title":"J Nutr Biochem"},{"issue":"12","key":"2981_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05863","volume":"6","author":"KS Olaniyi","year":"2020","unstructured":"Olaniyi KS, Sabinari IW, Olatunji LA. Oral L-glutamine rescues fructose-induced poor fetal outcome by preventing placental triglyceride and uric acid accumulation in Wistar rats. Heliyon. 2020;6(12):e05863. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05863.","journal-title":"Heliyon"},{"issue":"1","key":"2981_CR43","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0022-3565(24)36584-X","volume":"281","author":"CJ Meininger","year":"1997","unstructured":"Meininger CJ, Wu G. L-glutamine inhibits nitric oxide synthesis in bovine venular endothelial cells. J Pharmacol Exp Ther. 1997;281(1):448\u201353.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2981_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10(1):190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4.","journal-title":"Signal Transduct Target Ther"},{"key":"2981_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2024.101289","volume":"95","author":"M Cao","year":"2024","unstructured":"Cao M, Yang F, McClements DJ, Guo Y, Liu R, Chang M, et al. Impact of dietary n-6\/n-3 fatty acid ratio of atherosclerosis risk: a review. Prog Lipid Res. 2024;95:101289. https:\/\/doi.org\/10.1016\/j.plipres.2024.101289.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"2981_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6(1):94. https:\/\/doi.org\/10.1038\/s41392-020-00443-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2981_CR47","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/med.21251","volume":"33","author":"V Capra","year":"2013","unstructured":"Capra V, B\u00e4ck M, Barbieri SS, Camera M, Tremoli E, Rovati GE. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke. Med Res Rev. 2013;33(2):364\u2013438. https:\/\/doi.org\/10.1002\/med.21251.","journal-title":"Med Res Rev"},{"issue":"11","key":"2981_CR48","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/circresaha.116.310525","volume":"120","author":"V Garcia","year":"2017","unstructured":"Garcia V, Gilani A, Shkolnik B, Pandey V, Zhang FF, Dakarapu R, et al. 20-HETE signals through G-protein-coupled receptor GPR75 (G(q)) to affect vascular function and trigger hypertension. Circ Res. 2017;120(11):1776\u201388. https:\/\/doi.org\/10.1161\/circresaha.116.310525.","journal-title":"Circ Res"},{"issue":"1","key":"2981_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2011.09.031","volume":"52","author":"G Leonarduzzi","year":"2012","unstructured":"Leonarduzzi G, Gamba P, Gargiulo S, Biasi F, Poli G. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic Biol Med. 2012;52(1):19\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.09.031.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"2981_CR50","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/cvr\/cvab003","volume":"117","author":"L Badimon","year":"2021","unstructured":"Badimon L, Vilahur G, Rocca B, Patrono C. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Cardiovasc Res. 2021;117(9):2001\u201315. https:\/\/doi.org\/10.1093\/cvr\/cvab003.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"2981_CR51","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1016\/j.bbadis.2019.06.011","volume":"1865","author":"H Gallagher","year":"2019","unstructured":"Gallagher H, Williams JO, Ferekidis N, Ismail A, Chan YH, Michael DR, et al. Dihomo-\u03b3-linolenic acid inhibits several key cellular processes associated with atherosclerosis. Biochimica et Biophysica Acta (BBA). 2019;1865(9):2538\u201350. https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.011.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"2981_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.plefa.2010.02.032","volume":"83","author":"S Kakutani","year":"2010","unstructured":"Kakutani S, Kawashima H, Tanaka T, Shiraishi-Tateishi A, Kiso Y. Uptake of dihomo-gamma-linolenic acid by murine macrophages increases series-1 prostaglandin release following lipopolysaccharide treatment. Prostaglandins Leukot Essent Fatty Acids. 2010;83(1):23\u20139. https:\/\/doi.org\/10.1016\/j.plefa.2010.02.032.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"10","key":"2981_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103475","volume":"13","author":"DWT Nilsen","year":"2021","unstructured":"Nilsen DWT, Myhre PL, Kalstad A, Schmidt EB, Arnesen H, Seljeflot I. Serum levels of dihomo-gamma (\u03b3)-linolenic acid (DGLA) are inversely associated with linoleic acid and total death in elderly patients with a recent myocardial infarction. Nutrients. 2021;13(10):3475. https:\/\/doi.org\/10.3390\/nu13103475.","journal-title":"Nutrients"},{"issue":"3","key":"2981_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032116","volume":"24","author":"AM Mustonen","year":"2023","unstructured":"Mustonen AM, Nieminen P. Dihomo-\u03b3-Linolenic Acid (20:3n-6)\u2014Metabolism, Derivatives, and Potential Significance in Chronic Inflammation. Int J Mol Sci. 2023;24(3):2116. https:\/\/doi.org\/10.3390\/ijms24032116.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2981_CR55","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.tem.2022.08.002","volume":"33","author":"R Ortiz","year":"2022","unstructured":"Ortiz R, Kluwe B, Lazarus S, Teruel MN, Joseph JJ. Cortisol and cardiometabolic disease: a target for advancing health equity. Trends Endocrinol Metab. 2022;33(11):786\u201397. https:\/\/doi.org\/10.1016\/j.tem.2022.08.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2981_CR56","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s42255-025-01283-0","volume":"7","author":"KS Lee","year":"2025","unstructured":"Lee KS, Su X, Huan T. Metabolites are not genes - avoiding the misuse of pathway analysis in metabolomics. Nat Metab. 2025;7(5):858\u201361. https:\/\/doi.org\/10.1038\/s42255-025-01283-0.","journal-title":"Nat Metab"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02981-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T18:19:38Z","timestamp":1763576378000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02981-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02981-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"440"}}